These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36159594)

  • 1. A novel oncogenic enhancer of estrogen receptor-positive breast cancer.
    Bao C; Duan J; Xie Y; Liu Y; Li P; Li J; Zhao H; Guo H; Men Y; Ren Y; Xu J; Wang G; Lu W
    Mol Ther Nucleic Acids; 2022 Sep; 29():836-851. PubMed ID: 36159594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.
    Wang C; Mayer JA; Mazumdar A; Fertuck K; Kim H; Brown M; Brown PH
    Mol Endocrinol; 2011 Sep; 25(9):1527-38. PubMed ID: 21835891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of an enhancer element in the estrogen receptor upstream region: implications for regulation of ER transcription in breast cancer.
    Cohn CS; Sullivan JA; Kiefer T; Hill SM
    Mol Cell Endocrinol; 1999 Dec; 158(1-2):25-36. PubMed ID: 10630402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers.
    Tang Z; Treilleux I; Brown M
    Mol Cell Biol; 1997 Mar; 17(3):1274-80. PubMed ID: 9032254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.
    Alles MC; Gardiner-Garden M; Nott DJ; Wang Y; Foekens JA; Sutherland RL; Musgrove EA; Ormandy CJ
    PLoS One; 2009; 4(3):e4710. PubMed ID: 19270750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between ER and HER2 regulates c-MYC-mediated glutamine metabolism in aromatase inhibitor resistant breast cancer cells.
    Chen Z; Wang Y; Warden C; Chen S
    J Steroid Biochem Mol Biol; 2015 May; 149():118-27. PubMed ID: 25683269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G; Katzenellenbogen BS
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
    Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
    Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
    Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
    Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
    Kang Y; Cortina R; Perry RR
    J Natl Cancer Inst; 1996 Mar; 88(5):279-84. PubMed ID: 8614006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rearranged during transfection/papillary thyroid carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positive breast cancer cells.
    Wang C; Mayer JA; Mazumdar A; Brown PH
    Breast Cancer Res Treat; 2012 Jun; 133(2):487-500. PubMed ID: 21947652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.
    Barnett DH; Sheng S; Charn TH; Waheed A; Sly WS; Lin CY; Liu ET; Katzenellenbogen BS
    Cancer Res; 2008 May; 68(9):3505-15. PubMed ID: 18451179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-independent Myc overexpression confers endocrine therapy resistance on breast cancer cells expressing ERαY537S and ERαD538G mutations.
    Yu L; Wang L; Mao C; Duraki D; Kim JE; Huang R; Helferich WG; Nelson ER; Park BH; Shapiro DJ
    Cancer Lett; 2019 Feb; 442():373-382. PubMed ID: 30419347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLC22A5/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE).
    Wang C; Uray IP; Mazumdar A; Mayer JA; Brown PH
    Breast Cancer Res Treat; 2012 Jul; 134(1):101-15. PubMed ID: 22212555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of Y-box binding protein-1 expression modifies the response to endocrine therapy in estrogen receptor-positive breast cancer.
    Ito T; Kamijo S; Izumi H; Kohno K; Amano J; Ito K
    Breast Cancer Res Treat; 2012 May; 133(1):145-59. PubMed ID: 21863258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperation between the human estrogen receptor (ER) and MCF-7 cell-specific transcription factors elicits high activity of an estrogen-inducible enhancer from the trout ER gene promoter.
    Lazennec G; Kern L; Salbert G; Saligaut D; Valotaire Y
    Mol Endocrinol; 1996 Sep; 10(9):1116-26. PubMed ID: 8885246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.
    Shajahan-Haq AN; Cook KL; Schwartz-Roberts JL; Eltayeb AE; Demas DM; Warri AM; Facey CO; Hilakivi-Clarke LA; Clarke R
    Mol Cancer; 2014 Oct; 13():239. PubMed ID: 25339305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEN1 silencing triggers the dysregulation of mTORC1 and MYC pathways in ER+ breast cancer cells.
    Abou Ziki R; Teinturier R; Luo Y; Cerutti C; Vanacker JM; Poulard C; Bachelot T; Diab-Assaf M; Treilleux I; Zhang CX; Le Romancer M
    Endocr Relat Cancer; 2022 Aug; 29(8):451-465. PubMed ID: 35583188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.